AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt


Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans…


AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress


Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage…


AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft


Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical…


AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory


Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with…


AlloSource Launches Placental Donation Program


Centennial, Colo. — December 20, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts that advance patient healing, today announced the launch of the AlloSource Placental Donation Program. This initiative provides the opportunity for…


AlloSource Announces Raime Leeby Muhle As Chief Financial Officer


Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial…


American Heart Association Recognizes AlloSource For Workplace Health Achievements


Centennial, Colo. — December 5, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced it received recognition from the American Heart…


AlloSource Announces Bob Lay As Chief Operating Officer


Centennial, Colo. — November 7, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer.…


AlloSource To Highlight AlloFuse Select CM Cellular AlloGraft Matrix At North American Spine Society Annual Meeting


Centennial, Colo. — October 24, 2017 — AlloSource, one of the nation’s largest providers of cellular, cartilage, bone, skin and soft-tissue allografts to advance patient healing in surgical procedures, will highlight AlloFuse® Select CM at the North American Spine Society Annual Meeting (NASS).…


AlloSource President And CEO Thomas Cycyota Receives American Association Of Tissue Banks Award


Centennial, Colo. — October 10, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced that its President and Chief Executive Officer, Thomas…


AlloSource And Integra LifeSciences Announce Anchor Gifts To Phoenix Society For Burn Survivors’ Never Alone Campaign


Centennial, Colo. and Plainsboro, N.J. — October 5, 2017 — AlloSource, one of the nation’s largest providers of cellular and tissue allografts, and Integra LifeSciences, a leading global medical technology company, today announced anchor gift donations to the Phoenix Society for Burn Survivors’…


AlloSource Announces Milestone In Production Of Bioengineered Blood Vessels For Humacyte’s Vascular Access Phase III Clinical Trial


Centennial, Colo. – September 12, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, today announced a major milestone in its partnership with Humacyte. AlloSource…


Philadelphia Hand To Shoulder Center Of Thomas Jefferson University Announces Prospective Study On AlloWrap In The Hand And Wrist


Philadelphia, Pa. — August 8, 2017 — Researchers at the Philadelphia Hand to Shoulder Center (PHSC) of Thomas Jefferson University (TJU) today announced the initiation of a prospective, randomized trial for the treatment of tendon adhesions of the hand and wrist using AlloSource’s AlloWrap® DS, a…


AlloSource Releases AlloFuse Line Extentsion


Company adds AlloFuse Select CM, a cellular allograft matrix, to the AlloFuse portfolio Centennial, Colo. — August 1, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue, and cellular allografts to advance patient healing in surgical procedures and wound…


Cross-Country Bike Ride For Organ, Eye And Tissue Donation Kicking Off At AlloSource


Centennial, Colo. — June 30, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, today hosted the kickoff event for Pedal For Life’s cross-country bike ride to raise…


Stryker And AlloSource Announce Collaboration To Distribute Biologics For Use In Sports Medicine Procedures


Denver, Colorado, USA – May 18, 2017 – Today at the 2017 Annual Arthroscopy Association of North America (AANA) Meeting (booth #109), Stryker’s Sports Medicine business and AlloSource® formally announced their collaboration to provide high quality, innovative biologics for use in sports medicine…


AlloSource’s Burn Skin AlloGraft Rebranded To Pureskin


Company to feature PureSkin at the American Burn Association Annual Meeting Centennial, Colo. — March 20, 2017 — AlloSource, one of the nation’s largest providers of burn skin, cartilage, bone, soft-tissue and cellular allografts for use in surgical procedures and burn and wound care to advance…


Theracell And AlloSource Announce Second Patent For Bone Fiber Technology


Demineralized Bone Fiber (DBF™) patent to expand TheraCell’s osteobiologic patent portfolio Northridge, Cali. and Centennial, Colo. — March 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the…


AlloSource Announces The Annual Dr. Steven Gitelis Inspiration Award


Company honors Dr. Brian Cole with the inaugural award Centennial, Colo. — January 24, 2017 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, announced the…


AlloSource Business Process Manager Designated Malcolm Baldrige National Quality Award Examiner, Deepening Company’s Commitment To Performance Excellence


Centennial, Colo. — December 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures, recognized Kimberly Meyer, Business Process Manager, for being named to the Board of Examiners for the 2016 Malcolm…


TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology


Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands…


AlloSource Receives Phoenix Society For Burn Survivors’ Harman Award


Centennial, Colo. — October 21, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing, received the Phoenix Society for Burn Survivors’ Harman Award for philanthropic leadership. The award is presented to an…


International Cartilage Repair Society Symposia To Highlight Early Findings Of ProChondrix Cartilage Restoration Matrix


Centennial, Colo. — September 23, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix®…


AlloSource Supports NASA And Jet Propulsion Laboratory On Microbial Study


Centennial, CO — August 25, 2016 — AlloSource, one of the nation’s largest providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of cellular bone allografts, worked with NASA and the Jet Propulsion Laboratory (JPL) on microbial research…